We use cookies

Essential storage keeps the site working (sign-in, theme, this choice). We'd also like to load Google Analytics to understand, in aggregate, how the site is used — never your genetic data. See our Cookie Policy.

RHO rs121908147: Understanding the P23H Variant

rs121908147
Trait
Limited evidenceGene: RHO

The rs121908147 variant in the RHO gene, commonly referred to as the P23H mutation, is a well-studied genetic change associated with autosomal dominant retinitis pigmentosa. It alters the structure of the rhodopsin protein, which is essential for vision in low-light conditions.

What each genotype means

C/CLower attention

Typical rhodopsin gene profile

This genotype represents the common, non-variant form of the RHO gene at this position. It is not associated with the P23H substitution linked to autosomal dominant retinitis pigmentosa.

This is the most common genotype found in the general population globally.

C/AHigher attention

P23H variant carrier

This genotype indicates the presence of the Pro23His (P23H) substitution, which is a known cause of autosomal dominant retinitis pigmentosa. Individuals with this variant may experience progressive rod-cone dystrophy, night blindness, and visual field narrowing, though clinical expression can vary significantly between individuals. Please consult with an ophthalmologist or genetic counselor to discuss your specific clinical context and potential management options.

This variant is very rare globally but is a recognized founder mutation in North American populations, where it accounts for approximately 10% of autosomal dominant retinitis pigmentosa cases.

A/AHigher attention

P23H variant homozygous

This genotype indicates that both copies of the RHO gene carry the P23H substitution. Because this condition is typically inherited in an autosomal dominant manner, this genotype is associated with the clinical features of retinitis pigmentosa, such as progressive vision loss. Please consult with a medical professional or genetic specialist to understand the implications for your health and family planning.

This genotype is extremely rare and is not typically observed in the general population.

What is the rs121908147 Variant?

The variant rs121908147, often identified in scientific literature as the P23H mutation, represents a specific change in the DNA sequence of the RHO gene. In this substitution, the amino acid proline is replaced by histidine at position 23 of the rhodopsin protein. This specific alteration is one of the most frequently reported genetic causes of autosomal dominant retinitis pigmentosa (adRP) in North America. Because it is inherited in an autosomal dominant pattern, an individual typically only needs to inherit one copy of the altered gene from one parent to be at risk for the associated condition. This variant has been the subject of extensive research for decades, serving as a primary model for understanding how specific protein misfolding can lead to the degeneration of photoreceptor cells in the human eye.

The Role of the RHO Gene

The RHO gene provides instructions for making a protein called rhodopsin. Rhodopsin is found in rod cells, which are specialized photoreceptor cells located in the retina at the back of the eye. These cells are responsible for vision in low-light conditions, such as at night. When light hits the retina, it interacts with the rhodopsin protein, triggering a chemical signal that is sent to the brain to create a visual image. When the RHO gene contains a pathogenic variant like P23H, the resulting rhodopsin protein may be unstable or misfolded. This dysfunction interferes with the normal operation of rod cells, often causing them to self-destruct. Over time, the loss of these rod cells leads to the symptoms of retinitis pigmentosa, which typically begins with night blindness and can eventually progress to a loss of peripheral and central vision.

Research and Clinical Associations

Research into rs121908147 has established a strong link between this variant and autosomal dominant retinitis pigmentosa. Studies suggest that approximately 10% of adRP cases in North America may be attributed to this specific mutation. While the evidence for its role in retinal dystrophy is robust, the clinical expression can vary between individuals. Scientists have utilized various animal models, including pigs, rats, and mice, to study the mechanisms of photoreceptor degeneration caused by this variant. Recent meta-analyses and population modeling have attempted to estimate the prevalence of this variant, suggesting that while it is rare globally, it is significantly enriched in certain North American pedigrees. It is important to note that while the association with retinal disease is well-documented, the progression and severity of vision loss can be influenced by other genetic and environmental factors.

Population Frequency

The rs121908147 variant is considered very rare on a global scale. However, it is notably enriched within North American populations, particularly among specific autosomal dominant retinitis pigmentosa pedigrees. Recent studies indicate that the genetic prevalence of this variant in the United States is estimated to be higher than previously thought, with evidence suggesting it is not limited to individuals of European ancestry but is also present in African American and other non-European populations.

What This Information Means for You

Understanding your genetic status regarding rs121908147 is a matter of clinical significance that should be handled by healthcare professionals. If you have received results indicating the presence of this variant, it is essential to consult with a genetic counselor or an ophthalmologist who specializes in inherited retinal diseases. They can provide context based on your personal and family medical history, as well as discuss the current landscape of clinical research and potential management strategies. This information is for educational purposes and does not constitute a medical diagnosis. You should never make changes to your healthcare or lifestyle based solely on genetic data without professional guidance. Genetic testing for retinal conditions is complex, and a clinical evaluation is necessary to understand how a specific variant might impact your long-term eye health.

How common is this variant?

The variant is very rare globally but is enriched in North American autosomal dominant retinitis pigmentosa pedigrees across diverse ancestral backgrounds.

Frequently asked questions

What is the P23H mutation in the RHO gene?

The P23H mutation is a specific genetic change (rs121908147) in the RHO gene where the amino acid proline is replaced by histidine. It is a well-known cause of autosomal dominant retinitis pigmentosa.

Does having the P23H variant mean I will go blind?

The presence of this variant is associated with retinitis pigmentosa, a condition that causes progressive vision loss. However, the rate and severity of vision loss vary significantly between individuals, and you should discuss your specific prognosis with an eye specialist.

Is there a cure for RHO-associated retinitis pigmentosa?

Currently, there is no cure for retinitis pigmentosa caused by RHO variants. Researchers are actively studying the condition, and you should consult with a retinal specialist to learn about the latest clinical trials and management options.

How is this variant inherited?

This variant is inherited in an autosomal dominant pattern. This means that an individual typically only needs to inherit one copy of the variant from one parent to be at risk for the associated retinal condition.

Sources & further reading

Educational information only, last refreshed 9/28/2026. Not medical advice — these associations describe population statistics, not individual predictions.

Curious what your genotype is for rs121908147?

Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.

Get my report — $29

Related variants in RHO